Image may be NSFW.
Clik here to view.
The use of genomics and genetics to predict disease, prognosis, and optimal treatments for individuals is a promising development in medicine, but it will require successful academic-industry collaborations. In this second program of the “Meeting the Challenge of Conflicts of Interest” series, Patrick Groody , divisional vice president for research and development at Abbott Molecular and Dr. Richard Schwab, the director of the Moores UCSD Cancer Center Biorepository, look at where these collaborations are working and how to overcome barriers to productive partnerships. This series is presented by the Center for Ethics in Science and Technology in San Diego. Series: "Exploring Ethics" [Public Affairs] [Health and Medicine] [Science] [Show ID: 24057]
[YouTube Video]
[Audio Podcast]
[Video Podcast]
Clik here to view.
The use of genomics and genetics to predict disease, prognosis, and optimal treatments for individuals is a promising development in medicine, but it will require successful academic-industry collaborations. In this second program of the “Meeting the Challenge of Conflicts of Interest” series, Patrick Groody , divisional vice president for research and development at Abbott Molecular and Dr. Richard Schwab, the director of the Moores UCSD Cancer Center Biorepository, look at where these collaborations are working and how to overcome barriers to productive partnerships. This series is presented by the Center for Ethics in Science and Technology in San Diego. Series: "Exploring Ethics" [Public Affairs] [Health and Medicine] [Science] [Show ID: 24057]
[YouTube Video]
[Audio Podcast]
[Video Podcast]
